Key Takeaways
- • The British Business Bank commits £50m to Longwall Ventures' Fund 4, representing the maximum allowable investment under the Enterprise Capital Funds programme and serving as a cornerstone commitment to help the fund raise its target.
- • Longwall Fund 4 targets early-stage deep tech companies across advanced manufacturing, clean energy, defence, and life sciences sectors, with ticket sizes between £500,000 and £2m deployed across up to 16 portfolio companies.
- • This marks the fourth consecutive fund at Longwall to receive British Business Bank backing, demonstrating sustained institutional confidence in the firm's deep tech investment thesis and execution track record.
- • The programme fills an identified "equity gap" for early-stage, high-growth UK-based science and engineering companies, aligning with government industrial strategy objectives around long-term growth and skilled job creation.
Summary
Longwall Fund 4 will focus on early-stage deep tech companies incorporated in the United Kingdom, with particular emphasis on sectors including advanced manufacturing, clean energy, defence, and life sciences. The fund will deploy capital in cheques ranging from £500,000 to £2m per investment, targeting up to 16 portfolio companies while reserving material capital for follow-on funding rounds to support scaling.
Mark Sims, managing director and head of development equity funds at the British Business Bank, highlighted the strategic role of the Enterprise Capital Funds programme in channelling institutional capital to early-stage venture funds and cited OrganOx as an example of Longwall's portfolio success. Business Secretary Peter Kyle framed the commitment within the government's Modern Industrial Strategy, positioning early-stage deep tech investment as foundational to long-term economic growth, employment in skilled sectors, and rising living standards.
This commitment continues a multi-fund relationship between the British Business Bank and Longwall Ventures, reflecting sustained confidence in the firm's investment approach and historical deployment of capital. Longwall Venture Partners, founded in 2011 and based in Oxford, has established a focus on life science, healthcare, and technology sectors over its operational history.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.